Ohcanbohtosat - Aniruddha Amrite

  • Čájehuvvo 1 - 5 / 5
Aiddostahte ozu
  1. 1
    Modeling of Corneal and Retinal Pharmacokinetics after Periocular Drug Administration

    Modeling of Corneal and Retinal Pharmacokinetics after Periocular Drug Administration Dahkki Aniruddha Amrite, Henry F. Edelhauser, Uday B. Kompella

    Almmustuhtton 2008
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    Single Periocular Injection of Celecoxib-PLGA Microparticles Inhibits Diabetes-Induced Elevations in Retinal PGE<sub>2</sub>, VEGF, and Vascular Leakage

    Single Periocular Injection of Celecoxib-PLGA Microparticles Inhibits Diabetes-Induced Elevations in Retinal PGE<sub>2</sub>, VEGF, and Vascular Leakage Dahkki Aniruddha Amrite, Surya Ayalasomayajula, N. Cheruvu, Uday B. Kompella

    Almmustuhtton 2006
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Nanomedicines for back of the eye drug delivery, gene delivery, and imaging

    Nanomedicines for back of the eye drug delivery, gene delivery, and imaging Dahkki Uday B. Kompella, Aniruddha Amrite, Rashmi Pacha Ravi, Shelley A. Durazo

    Almmustuhtton 2013
    Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  4. 4
    Safety, pharmacodynamics, and exposure-response modeling results from a first-in-human phase 1 study of nedosiran (PHYOX1) in primary hyperoxaluria

    Safety, pharmacodynamics, and exposure-response modeling results from a first-in-human phase 1 study of nedosiran (PHYOX1) in primary hyperoxaluria Dahkki Bernd Höppe, Annelize Koch, Pierre Cochat, Sander F. Garrelfs, Michelle A. Baum, Jaap W. Groothoff, Graham Lipkin, Martin Coenen, Gesa Schalk, Aniruddha Amrite, David McDougall, Kelly Barrios, Craig B. Langman

    Almmustuhtton 2021
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  5. 5
    PHYOX2: a pivotal randomized study of nedosiran in primary hyperoxaluria type 1 or 2

    PHYOX2: a pivotal randomized study of nedosiran in primary hyperoxaluria type 1 or 2 Dahkki Michelle A. Baum, Craig B. Langman, Pierre Cochat, John C. Lieske, Shabbir H. Moochhala, Shuzo Hamamoto, Hiroyuki Satoh, Chebl Mourani, Gema Ariceta, Armando Torres, Martin Wolley, Vladimir Belostotsky, Thomas Forbes, Jaap W. Groothoff, Wesley Hayes, Burkhard Tönshoff, Tatsuya Takayama, R. Roßkamp, Kerry Russell, Jing Zhou, Aniruddha Amrite, Bernd Höppe

    Almmustuhtton 2022
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: